66
T. M. Potewar et al. / Carbohydrate Research 379 (2013) 60–67
IR (CHCl3): 3022, 2957, 2855, 1749, 1613, 1552, 1506, 1482,
1H, H-10), 4.11–4.17 (m, 2H, H-10 & H-6), 4.24–4.34 (m, 2H, H-6 &
H-5), 4.46–4.51 (m, 1H, H-50), 4.70–4.75 (m, 1H, H-60), 4.85 (dd,
1455, 1435, 1366, 1221, 1043 cmꢁ1
.
1H NMR (CDCl3, 400 MHz): d ppm 2.04 (s, 3H, CH3), 2.06 (s, 3H,
CH3), 2.08 (s, 6H, 2 ꢂ CH3), 2.12 (s, 3H, CH3), 2.13 (s, 3H, CH3), 2.18
J5 ,6 = 4.0 Hz, J6 ,6 = 14.3 Hz, 1H, H-60), 4.94 (dd, J1,2 = 3.6 Hz,
J2,3 = 10.4 Hz, 1H, H-2), 5.06 (t, J3,4 = J4,5 = 9.9 Hz, 1H, H-4), 5.31 (d,
J = 3.0, 2H, triazole-CH2O), 5.40–5.55 (m, 3H, H-40, H-3, H-30), 5.40
(t, JCH2-O = 1.5 Hz, 1H, CH2=), 5.62 (d, J1,2 = 3.6 Hz, 1H, H-1), 6.13
(s, 1H, CH2=), 7.80 (s, 1H, triazole H).
0
0
0
0
(s, 3H, CH3), 3.94 (s, 3H, OCH3), 3.98 (d, J1 ,1 = 12.1 Hz, 1H, H-10),
4.11–4.20 (m, 2H, H-10 & H-6), 4.30–4.38 (m, 2H, H-5 & H-6),
4.52–4.56 (m, 1H, H-50), 4.76–4.82 (m, 1H, H-60), 4.92 (d,
0
0
J6 ,6 = 14.1 Hz, 1H, H-60), 4.98 (dd, J1,2 = 3.5 Hz, J2,3 = 10.5 Hz, 1H,
H-2), 5.09 (t, J3,4 = J4,5 = 9.8 Hz, 1H, H-4), 5.47–5.58 (m, 3H, H-40,
H-3, H-30), 5.69 (d, J1,2 = 3.4 Hz, 1H, H-1), 7.15–7.19 (m, 2H,
ArH5,7), 7.79–7.82 (m, 2H, ArH3,4), 7.92 (d, JAr7,8 = 8.4 Hz, 1H,
ArH), 8.04 (s, 1H, triazole H), 8.32 (s, 1H, ArH1).
13C NMR (CDCl3, 100 MHz): d ppm 18.4 (–C(CH3)@), 20.3 (–
COCH3), 20.4 (–COCH3), 20.5 (–COCH3), 52.6 (C-60), 57.6 (triazole-
CH2O), 61.1 (C-6), 62.5 (C-10), 68.1 (C-4), 68.9 (C-5), 69.1 (C-3),
69.9 (C-2), 74.9 (C-30), 75.4 (C-40), 79.2 (C-50), 90.0 (C-1), 103.6
(C-20), 125.2 (CH of triazole), 126.1 (CH2@C-CH3), 135.8 (–
C(CH3)@, 142.8 (Cquat triazole), 166.9 (CO), 169.4 (CO), 169.6
(CO), 169.8 (CO), 169.9, 170.0 (CO), 170.1 (CO), 170.3 (CO).
MALDI TOF MS calcd for C33H44N3O19: [M+H]+ 786.2569; found
786.2564.
0
0
13CNMR(CDCl3, 100 MHz):dppm 20.4 (CH3), 20.5 (CH3), 20.6 (CH3),
52.9 (C-60), 55.3 (OCH3), 62.2 (C-6), 62.7 (C-10), 68.3 (C-4), 69.0 (C-5),
69.2 (C-3), 70.0 (C-2), 74.9 (C-30), 75.3 (C-40), 79.2 (C-50), 90.0 (C-1),
103.7 (C-20), 105.7 (ArH) 119.3 (ArH), 121.1 (CH of triazole), 124.3
(ArH). 124.5 (ArH), 125.30 (ArCquat), 127.4 (ArH), 128.9 (ArCquat),
129.7 (ArH), 134.4 (ArCquat), 147.9 (Cquat triazole), 158.0 (ArCquat),
169.5, 169.7, 169.9, 170.0, 170.2, 170.3, 170.5 (CO).
3.14. 1-(10,2,3,30,4,40,6-Hepta-O-acetyl-60-deoxy-sucros-60-yl)-4-
(acetoxymethyl)-1,2,3-triazole (6i)
MALDI TOF MS calcd for C39H45N3O18Na: [M+Na]+ 866.2596;
found 866.2590.
Compound 6i (195 mg, 85.6%) has been obtained from 4
(200 mg, 0.30 mmol) and propargyl acetate 5i (75
by the general procedure at 50 °C. The propargyl acetate was added
in two portions.
lL, 0.76 mmol)
3.12. 1-(10,2,3,30,4,40,6-Hepta-O-acetyl-60-deoxy-sucros-60-yl)-4-
(acryloxymethyl)-1,2,3-triazole (6g)
Colorless solid; mp 53–54 °C.
Compound 6g (315 mg, 90.7%) has been obtained from 4
½
a 2D5
ꢃ
+72.8 (c 0.5, CHCl3).
IR (CHCl3): 3018, 2965, 1745, 1455, 1433, 1368, 1225,
(300 mg, 0.45 mmol) and propargyl acrylate 5g (75
by the general procedure.
lL, 0.68 mmol)
1039 cmꢁ1
.
Colorless solid; mp 58–59 °C.
1HNMR(CDCl3, 400 MHz):dppm 2.04 (s, 3H, CH3), 2.05 (s, 3H, CH3),
2.09 (s, 9H, 3 ꢂ CH3), 2.12 (s, 3H, CH3), 2.13 (s, 3H, CH3), 2.19 (s, 3H,
½
a 2D5
ꢃ
+53.2 (c 0.5, CHCl3).
IR (CHCl3): 3014, 2961, 2851, 2125, 1749, 1409, 1378, 1225,
CH3), 3.96 (d, J1 ,1 = 12.1 Hz, 1H, H-10), 4.11–4.16 (m, 2H, H-10 & H-6),
0
0
1043 cmꢁ1
.
4.25–4.33 (m, 2H, H-5 & H-6), 4.45–4.49 (m, 1H, H-50), 4.70–4.75 (m,
1H NMR (CDCl3, 400 MHz): d ppm 2.03 (s, 3H, CH3), 2.04 (s, 3H,
CH3), 2.08 (s, 6H, 2 ꢂ CH3), 2.11 (s, 3H, CH3), 2.12 (s, 3H, CH3), 2.19
1H, H-60), 4.84 (dd, J5 ,6 = 3.8 Hz, J6 ,6 = 14.1 Hz, 1H, H-60), 4.94 (dd,
J1,2 = 3.6 Hz, J2,3 = 10.7 Hz, 1H, H-2), 5.06 (t, J3,4 = J4,5 = 9.9 Hz, 1H, H-
4), 5.23 (d, JH–C–H = 3.9, 2H, –CH2O), 5.39–5.55 (m, 3H, H-40, H-3, H-
30), 5.61 (d, J1,2 = 3.6 Hz, 1H, H-1), 7.77 (s, 1H, triazole H).
13C NMR (CDCl3, 100 MHz): d ppm 20.4 (CH3), 20.5 (CH3), 20.8
(CH3), 52.8 (C-60), 57.3 (–CH2O), 62.1 (C-6), 62.5 (C-10), 68.2 (C-4),
69.0 (C-5), 69.1 (C-3), 70.1 (C-2), 74.9 (C-30), 75.4 (C-40), 79.3 (C-
50), 90.1 (C-1), 103.7 (C-20), 125.2 (CH of triazole), 142.7 (Cquat tri-
azole), 169.4, 169.7, 169.9, 170.0, 170.1, 170.2, 170.5, 170.7 (CO).
MALDI TOF MS calcd for C31H41N3O19Na: [M+Na]+ 782.2232;
found 782.2226.
0
0
0
0
(s, 3H, CH3), 3.95 (d, J1 ,1 = 12.1 Hz, 1H, H-10), 4.11–4.16 (m, 2H, H-
0
0
10 & H-6), 4.24–4.33 (m, 2H, H-5 & H-6), 4.45–4.50 (m, 1H, H-50),
4.69–4.75 (m, 1H, H-60), 4.85 (dd, J5 ,6 = 3.8 Hz, J6 ,6 = 14.2 Hz, 1H,
H-60), 4.94 (dd, J1,2 = 3.6 Hz, J2,3 = 10.5 Hz, 1H, H-2), 5.06 (t,
J3,4 = J4,5 = 9.8 Hz, 1H, H-4), 5.32 (d, J = 2.3, 2H, triazole-CH2O),
5.40–5.55 (m, 3H, H-40, H-3, H-30), 5.61 (d, J1,2 = 3.4 Hz, 1H, H-1),
5.86 (dd, JCH-CH2 = 1.3 Hz, JH–C–H = 17.40 Hz, 1H, CH2@), 6.11–6.18
(m, 1H, –CH@), 6.44 (dd, JCH-CH2 = 1.32 Hz, JH–C–H = 17.40 Hz, 1H,
CH2=), 7.80 (s, 1H, triazole H).
0
0
0
0
13C NMR (CDCl3, 100 MHz): d ppm 20.4 (CH3), 20.5 (CH3), 20.6
(CH3), 52.8 (C-60), 57.4 (CH2), 62.2 (C-6), 62.6 (C-10), 68.2 (C-4),
69.0 (C-5), 69.1 (C-3), 70.0 (C-2), 74.9 (C-30), 75.5 (C-40), 79.3 (C-
50), 90.1 (C-1), 103.7 (C-20), 125.3 (CH of triazole), 127.9 (CH2=),
131.5 (–CH@), 142.6 (Cquat triazole), 165.8 (CO), 169.5 (CO),
169.7 (CO), 169.9 (CO), 170.0 (CO), 170.1 (CO), 170.2 (CO), 170.4
(CO).
3.15. 1-(10,2,3,30,4,40,6-Hepta-O-acetyl-60-deoxy-sucros-60-yl)-4-
(cyclohexyl)-1,2,3-triazole (6j)
Compound 6j (152 mg, 85.9%) has been obtained from 4
(150 mg, 0.23 mmol) and cyclohexylacetylene 5j (45
0.34 mmol) by the general procedure.
lL,
MALDI TOF MS calcd C32H41N3O19Na: [M+Na]+ 794.2232; found
794.2226.
Colorless solid; mp 53–54 °C.
½
a 2D5
ꢃ
+80.8 (c 0.5, CHCl3).
3.13. 1-(10,2,3,30,4,40,6-Hepta-O-acetyl-60-deoxy-sucros-60-yl)-4-
(methacryloxymethyl)-1,2,3-triazole (6h)
IR (CHCl3): 3022, 2933, 2855, 1749, 1497, 1433, 1372, 1223,
1043 cmꢁ1
.
1H NMR (CDCl3, 400 MHz): d ppm 1.24–1.82 (m, 10H, –CH2),
2.04 (s, 6H, 2 ꢂ CH3), 2.08 (s, 3H, CH3), 2.09 (s, 3H, CH3), 2.10 (s,
3H, CH3), 2.13 (s, 3H, CH3), 2.19 (s, 3H, CH3), 2.74–2.79 (m, 1H,
Compound 6h (291 mg, 82.3%) has been obtained from 4
(300 mg, 0.45 mmol) and propargyl acrylate 5h (84 mg,
0.68 mmol) by the general procedure.
CH, cyclohexaneCH), 3.98 (d, J1 ,1 = 12.1 Hz, 1H, H-10), 4.11–4.18
(m, 2H, H-10 & H-6), 4.22–4.33 (m, 2H, H-6, H-5), 4.46–4.50 (m,
1H, H-50), 4.63–4.69 (m, 1H, H-60), 4.78 (dd, J5´,6´ = 3.9 Hz,
J6´,6´ = 14.1 Hz, 1H, H-60), 4.95 (dd, J1,2 = 3.6 Hz, J2,3 = 10.6 Hz, 1H, H-
2), 5.06 (t, J3,4 = J4,5 = 9.8 Hz, 1H, H-4), 5.41–5.54 (m, 3H, H-40, H-3
& H-30), 5.62 (d, J1,2 = 3.5 Hz, 1H, H-1), 7.40 (s, 1H, triazole H).
13C NMR (CDCl3, 100 MHz): d ppm 20.4 (CH3), 20.5 (CH3), 20.6
(CH3), 25.9 (cyclohexaneCH2), 26.0 (cyclohexaneCH2), 32.8 (cyclo-
0
0
Colorless solid; mp 47–48 °C.
½
a 2D5
ꢃ
+79.2 (c 0.5, CHCl3).
IR (CHCl3): 3022, 2961, 1751, 1435, 1316, 1291, 1225,
1041 cmꢁ1
.
1H NMR (CDCl3, 400 MHz): d ppm 1.94 (s, 3H, CH3 methacryl),
2.04 (s, 6H, 2 ꢂ CH3), 2.08 (s, 3H, CH3), 2.09 (s, 3H, CH3), 2.11 (s,
0
0
3H, CH3), 2.12 (s, 3H, CH3), 2.19 (s, 3H, CH3), 3.97 (d, J1 ,1 = 12.1 Hz,